Pelthos Therapeutics Inc. · Brief

Next report

12 days

Nov 12 · before openest.Q3 FY26

Expected move

No implied move.

5 reportsHistory

—≥ implied

Q3 FY25—▲+1.43%—

Nov 13 '25—▼−7.27%—

Q1 FY26—▼−4.62%—

May 14 '26—▲+6.46%—

Q2 FY26—▲+0.14%—

quarterimplied−10%0+10%realized×

Q2 FY26—▲+0.14%—

May '26—▲+6.46%—

Q1 FY26—▼−4.62%—

Nov '25—▼−7.27%—

Q3 FY25—▲+1.43%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 12 report · est.

Bull1

23managers reporting a position in the latest quarter13F · Jun 30 '26

Bear2 of 3

35.00%share of revenue from the largest disclosed customerSEC filings

5portion of reported manager value held by top managers13F · Jun 30 '26

AI captions · Oct 26 '26once per report · top 2 per case

PTHS report session

No linked exposure.

Oct 308-KMaterial agreement: Merger Agreement with Castle Creek Biosciences, Inc.Source

Oct 30haltTrading halt: 09:34 ET, resumed 09:39 ET.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.